Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Modifying factors of PD-L1 expression on tumor cells in advanced non-small-cell lung cancer.
Avilés-Salas A, Flores-Estrada D, Lara-Mejía L, Catalán R, Cruz-Rico G, Orozco-Morales M, Heredia D, Bolaño-Guerra L, Soberanis-Piña PD, Varela-Santoyo E, Cardona AF, Arrieta O. Avilés-Salas A, et al. Among authors: lara mejia l. Thorac Cancer. 2022 Dec;13(23):3362-3373. doi: 10.1111/1759-7714.14695. Epub 2022 Oct 31. Thorac Cancer. 2022. PMID: 36317227 Free PMC article.
Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: the THOCOoP cooperative group.
Arrieta O, Cardona AF, Lara-Mejía L, Heredia D, Barrón F, Zatarain-Barrón ZL, Lozano F, de Lima VC, Maldonado F, Corona-Cruz F, Ramos M, Cabrera L, Martin C, Corrales L, Cuello M, Arroyo-Hernández M, Aman E, Bacon L, Baez R, Benitez S, Botero A, Burotto M, Caglevic C, Ferraris G, Freitas H, Kaen DL, Lamot S, Lyons G, Mas L, Mata A, Mathias C, Muñoz A, Patane AK, Oblitas G, Pino L, Raez LE, Remon J, Rojas L, Rolfo C, Ruiz-Patiño A, Samtani S, Viola L, Viteri S, Rosell R. Arrieta O, et al. Crit Rev Oncol Hematol. 2020 Sep;153:103033. doi: 10.1016/j.critrevonc.2020.103033. Epub 2020 Jun 20. Crit Rev Oncol Hematol. 2020. PMID: 32650215 Free PMC article. Review.
Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 study.
Blake-Cerda M, Lozano-Ruíz F, Maldonado-Magos F, de la Mata-Moya D, Díaz-García D, Lara-Mejía L, Zatarain-Barrón ZL, Cuevas-Góngora MF, Barron-Barron F, Corona-Cruz JF, Cabrera-Miranda L, Arroyo-Hernández M, Gerson R, Arrieta O. Blake-Cerda M, et al. Lung Cancer. 2021 Feb;152:119-126. doi: 10.1016/j.lungcan.2020.12.029. Epub 2020 Dec 28. Lung Cancer. 2021. PMID: 33385737 Clinical Trial.
Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung Cancer.
Arrieta O, Varela-Santoyo E, Cardona AF, Sánchez-Reyes R, Lara-Mejía L, Bassarmal SS, Valle-Bautista D, Corrales-Rodríguez L, Motola-Kuba D, Cabrera-Miranda L, Martín C. Arrieta O, et al. Clin Lung Cancer. 2021 Nov;22(6):510-522. doi: 10.1016/j.cllc.2021.03.014. Epub 2021 Mar 27. Clin Lung Cancer. 2021. PMID: 33947631
25 results